Bringing the fundamentals into focus…
Back to Definium Therapeutics, Inc.
How Definium Therapeutics, Inc. stacks up
DFTX · against 244 other Healthcare companies of similar size
Valuation
33/ 100
Below the middle of the pack.
Ranked #177 of 245 · scores higher than 26% of peers
Bars: peers in each 10-point band of the valuation score19 peers with a valuation score of 30–39, including DFTX · Click a bar to see the companies
Why valuation scores 33?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, which is weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -7.9% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -3.7% vs peer median 0.0%
- EBITDA yield is not reported, so it is left out of the score.
Metric by metric
Position: dot = DFTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | DFTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 241 reported | -10.3% | 2.4% | 7% | 30% | |
| EBITDA yieldHigher is better · 241 reported | Not reported | 4.6% | — | — | 50% |
| Free cash flow yieldHigher is better · 129 reported | -3.7% | 0.6% | 27% | 20% | |
| Book yieldHigher is better · 242 reported | 20.5% | 26.9% | 40% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around DFTX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 4 | 21.1B HKD (≈$2.7B) | 98 | 67 | |
| 4 | 428.3B JPY (≈$2.9B) | 98 | 59 | |
| 172 | 2.7B USD | 37 | 44 | |
| 175 | 18.7B CNY (≈$2.6B) | 36 | 51 | |
| 175 | 3.1B USD | 36 | 53 | |
| 177 | 6.1B USD | 33 | ||
| 177 | 4.5B USD | 33 | 33 | |
| 177 | 5.6B USD | 33 | 53 | |
| 177 | 8.8B USD | 33 | 50 | |
| 177 | 3.3B USD | 33 | 39 | |
| 182 | 8.9B USD | 32 | 51 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score